Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-12 | 2019-04-24 | 81528 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-12 | 2019-04-24 | 81530 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-05-23 | 2019-11-23 | 84606 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-08-07 | 2020-08-20 | 121934 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2019-05-23 | 2019-06-19 | 84603 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-02-20 | 2020-03-05 | 106777 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-12-10 | 2020-12-17 | 129949 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2019-08-15 | 2019-08-24 | 91651 |
| IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2019-04-01 | 2019-05-06 | 80252 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| AVAPRO | 75MG | TABLET | To be discontinued | 2024-05-31 | 2024-05-31 | 229306 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
| MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |